News
I had a symptom of colon cancer and family history, so I got a colonoscopy. It was expensive, and insurance was a nightmare, ...
2d
Health and Me on MSNIBS Cases Surged During COVID-19 Pandemic, Study FindsA recent study shows IBS rates among U.S. adults nearly doubled during the pandemic, rising from 6% to 11%, likely due to ...
But a new study published in the journal Cells has raised questions about the long-term safety of FMT treatments, suggesting ...
Design We performed this study in 52 adult patients with moderate-to-severe IBS. At the screening visit, clinical history and symptoms were assessed and faecal samples were collected. Patients were ...
The Rome criteria for IBS are: 1) Recurrent abdominal pain on average at least one day per week in the last three months, associated with two or more of the following criteria: Related to defecation ...
SAN DIEGO — Rifaximin plus N-acetylcysteine outperformed rifaximin alone among patients with diarrhea-predominant irritable bowel syndrome, improving bloating, diarrhea and pain, according to ...
Digestive issues like IBS and Sibo can mimic each other, but understanding their differences – and the role of our gut microbiome – could be key to feeling better.
People with IBS also tend to be more sensitive to gluten, advise experts. A low FODMAP diet reduces the amount of hard-to-digest carbohydrates and may help those with IBS as well.
Prescription medications specifically for IBS-C: Linaclotide (Linzess) and lubiprostone (Amitiza) increase fluid secretion in the intestines to soften stool and increase bowel movements.
IBS-C makes up about a third of all IBS cases. While it can cause chronic (long-term) discomfort, getting a diagnosis and implementing a recommended treatment plan can help make IBS-C manageable.
Stool samples will also undergo traditional microbiome analyses (diversity and abundance) and faecal calprotectin assays. Additional serum analyses will aim to determine if a proteomics-based ...
Irritable bowel syndrome, or IBS, is among the most common gastrointestinal conditions today. It affects some 10% to 15% of people in the U.S., per the American College of Gastroenterology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results